Literature DB >> 2476640

The expression of the proto-oncogene C-kit in the blast cells of acute myeloblastic leukemia.

C Wang1, J E Curtis, E N Geissler, E A McCulloch, M D Minden.   

Abstract

The oncogene kit has been shown genetically to map in the W locus of the mouse. This locus is known to have an important role in the regulation of normal hemopoietic stem cell growth. The blast cells of acute myeloblastic leukemia may be considered to arise in predeterministic stem cells. Accordingly, we sought evidence that kit was involved in the regulation of AML blast growth, using a cDNA probe to the external domain of c-kit. With this probe the gene was found to be in germline configuration in blast cells from AML, ALL, and continuous myeloblastic cell lines. However, expression could be detected by Northern analysis or RNA dot blots only in fresh AML blast cells. Fresh cells from ALL patients, normal bone marrow, PHA-stimulated lymphocytes, and four myeloblastic continuous cell lines were expression negative by the same techniques.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476640

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  19 in total

1.  Paediatric mastocytosis.

Authors:  M C Carter; D D Metcalfe
Journal:  Arch Dis Child       Date:  2002-05       Impact factor: 3.791

2.  Screening of the c-kit gene missense mutation in invasive ductal carcinoma of breast among north Indian population.

Authors:  Syed Rizwan Hussain; Sunil G Babu; Syed Tasleem Raza; Pradyumn Singh; Faisal Ahmed; Hena Naqvi; Farzana Mahdi
Journal:  Mol Biol Rep       Date:  2012-06-24       Impact factor: 2.316

Review 3.  Not Only Mutations Matter: Molecular Picture of Acute Myeloid Leukemia Emerging from Transcriptome Studies.

Authors:  Luiza Handschuh
Journal:  J Oncol       Date:  2019-07-30       Impact factor: 4.375

4.  An aptamer-based targeted delivery of miR-26a protects mice against chemotherapy toxicity while suppressing tumor growth.

Authors:  Toshihiko Tanno; Peng Zhang; Christopher A Lazarski; Yang Liu; Pan Zheng
Journal:  Blood Adv       Date:  2017-06-22

Review 5.  Targeting the c-kit receptor in the treatment of acute myelogenous leukemia.

Authors:  Anjali S Advani
Journal:  Curr Hematol Malig Rep       Date:  2006-06       Impact factor: 3.952

6.  Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.

Authors:  T Furitsu; T Tsujimura; T Tono; H Ikeda; H Kitayama; U Koshimizu; H Sugahara; J H Butterfield; L K Ashman; Y Kanayama
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

7.  Human piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor gene.

Authors:  R A Fleischman
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

8.  Role of the KIT protooncogene in normal and malignant human hematopoiesis.

Authors:  M Z Ratajczak; S M Luger; K DeRiel; J Abrahm; B Calabretta; A M Gewirtz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

9.  C-kit receptor (CD117) expression in acute leukemia.

Authors:  L R Valverde; E Matutes; N Farahat; A Heffernan; K Owusu-Ankomah; R Morilla; D Catovsky
Journal:  Ann Hematol       Date:  1996-01       Impact factor: 3.673

10.  c-KIT expression enhances the leukemogenic potential of 32D cells.

Authors:  Q Hu; M Trevisan; Y Xu; W Dong; S A Berger; S D Lyman; M D Minden
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.